Participation of the Cholinergic System in the Development of Polycystic Ovary Syndrome

• Published in: Molecules
• Main Authors: Rosa Linares, Xóchitl N. Acuña, Gabriela Rosas, Elizabeth Vieyra, Deyra A. Ramírez, Andrea Chaparro, Julieta A. Espinoza, Roberto Domínguez, Leticia Morales-Ledesma
• Format: Article
• Language: English
• Published: MDPI AG 2021-09-01
• Subjects: PCOS; acetylcholine; atropine; ovulation; steroidogenesis
• Online Access: https://www.mdpi.com/1420-3049/26/18/5506

In rats with polycystic ovary syndrome (PCOS) induced by injection of estradiol valerate (EV), unilateral or bilateral section of the vagus nerve restores ovulatory function in 75% of animals, suggesting that the vagus nerve participates in the development of PCOS. Since the vagus nerve is a mixed nerve through which mainly cholinergic-type information passes, the objective of the present study was to analyze whether acetylcholine (ACh) is involved in the development of PCOS. Ten-day-old rats were injected with 2.0 mg EV, and at 60 days of age, they were microinjected on the day of diestrus in the bursa of the left or right ovary with 100 or 700 mg/kg of ovarian weight atropine, a blocker of muscarinic receptors, and sacrificed for histopathological examination after the surgery. Animals with PCOS microinjected with 100 mg of atropine showed a lack of ovulation, lower serum concentrations of progesterone and testosterone, and cysts. Histology of the ovaries of animals microinjected with 700 mg of atropine showed corpus luteum and follicles at different stages of development, which was accompanied by a lower concentration of progesterone and testosterone. These results allow us to suggest that in animals with PCOS, ACh, which passes through parasympathetic innervation, is an important component in the persistence and development of the pathophysiology.